Jupiter Life Line Hospitals Limited will host an earnings conference call on Monday, August 3, 2026, at 10:00 AM IST to discuss its operational and financial performance for the first quarter of fiscal year 2027 (Q1FY27). This disclosure, filed with the National Stock Exchange of India Ltd. and BSE Limited on July 27, 2026, informs investors and analysts of the upcoming briefing regarding the company's latest quarterly results. The event provides stakeholders with a direct channel to management for queries concerning revenue generation, profitability metrics, and strategic initiatives undertaken during the period.

The conference call is conducted in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates timely disclosure of material events to stock exchanges. Suma Upparatti, Company Secretary & Compliance Officer, signed the intimation letter addressed to both exchanges. The company has made the invitation details available on its official website, www.jupiterhospital.com , ensuring transparency and accessibility for all market participants.

Dr. Ankit Thakker, Managing Director and CEO, will lead the discussion alongside the senior management team. Their participation allows investors to gain insights into the healthcare sector dynamics affecting Jupiter Life Line Hospitals Limited during Q1FY27. The management team is expected to address questions related to patient inflow, bed occupancy rates, service mix changes, and any significant operational developments that influenced the financial outcomes.

Investors can participate in the call using the following access numbers:

Pre-registration for the call is requested through the link provided in the official invite. Strategic Growth Advisors Pvt. Ltd., represented by Mandar Chavan and Rahul Agarwal, are facilitating the event logistics.

What to Expect

While specific financial figures for Q1FY27 are not detailed in this pre-call intimation, the earnings call will serve as the primary source for the company's quarterly performance data. Analysts will likely focus on year-over-year growth trends, margin expansion or contraction, and capital expenditure plans. The outcome of this discussion may influence investor sentiment and valuation metrics for the stock listed as JLHL on NSE and code 543980 on BSE.

Jupiter Life Line Hospitals Limited held its 24th Annual General Meeting on July 17, 2026, approving the sub-division of equity shares and appointing Dr. Ajay Thakker as Chairman & Whole Time Director. The meeting, conducted via Video Conferencing, saw 85.95% of the outstanding shares polled, with all resolutions passed with the requisite majority. The company fixed Friday, July 24, 2026, as the record date for the share split, which will convert each equity share of ₹10 into five fully paid-up equity shares of ₹2 each.

The voting results were submitted to the National Stock Exchange of India Ltd. and BSE Limited in compliance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Vaibhav Dandawate, Partner of M/s. Makarand M. Joshi & Co., served as the Scrutinizer for the e-voting process. Remote e-voting commenced on July 14, 2026, and concluded on July 16, 2026.

Voting Summary

The total number of shareholders on the record date, July 10, 2026, was 32,977. Promoters did not vote on the resolution regarding the material related party transaction with Jupiter Hospital Projects Private Limited, in accordance with Regulation 23(4) of the Listing Regulations.

Key Resolutions

The resolution for the material related party transaction saw 42.82% of the outstanding shares polled, with 100% of votes cast in favour. The statutory auditors' and secretarial auditors' reports for FY26 contained no adverse remarks or qualifications. The alteration of the Articles of Association was approved as a Special Resolution, while the share split and alteration of the Capital Clause were approved as Ordinary Resolutions.